secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARVINAS, INC. (ARVN)
CIK:        0001655759
Form:       8-K
Filed at:   2024-06-17T23:59:59+00:00
Accession:  0001655759-24-000091
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Arvinas appoints Ian Taylor as President of R&D, Angela Cacace as CSO
---------------------------------------------------------------------

- Ian Taylor, Ph.D., formerly CSO, becomes President of R&D effective June 15, 2024.
- Angela Cacace, Ph.D., formerly SVP Neuroscience and Platform Biology, appointed CSO.
- Cacace joined Arvinas in 2018 and will drive early research pipeline.
- Taylor will also chair the company's scientific advisory board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1655759/000165575924000091/0001655759-24-000091-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1655759/000165575924000091/arvn-20240615.htm
  HTML page:      https://secwatch.observer/filing/0001655759-24-000091

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer